Skip to content
  • Thursday, 17 September 2026
  • 2:55 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead and Nucleai probe why target-positive tumors can still resist ADCs
Laboratory Automation & Robotics

Gilead and Nucleai probe why target-positive tumors can still resist ADCs

Lana Keisha Sep 17, 2026 0

Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, offering a sophisticated "seek-and-destroy" mechanism that couples the precision…

Read More
US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved DrugsScientific Breakthrough at the University of Auckland Reveals Hidden Atomic Mysteries of Gallium and Redefines Understanding of Liquid MetalsLilly’s retatrutide shows 28.3% weight loss, but increased side effectsTakeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
How Muscles and Movement Direct Neural Repair at the Cellular LevelAmsbio Unveils StemFit Basic04CT to Streamline Human Pluripotent Stem Cell Culture from Research to Clinical ManufacturingGilead and Nucleai probe why target-positive tumors can still resist ADCsScientists recreated what mice saw from brain activity alone
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
How Muscles and Movement Direct Neural Repair at the Cellular Level
Dwi Wanna Sep 17, 2026
Biotech & Genetic Research
Amsbio Unveils StemFit Basic04CT to Streamline Human Pluripotent Stem Cell Culture from Research to Clinical Manufacturing
Jia Lissa Sep 17, 2026
Laboratory Automation & Robotics
Gilead and Nucleai probe why target-positive tumors can still resist ADCs
Lana Keisha Sep 17, 2026
Neuroscience & Brain Research
Scientists recreated what mice saw from brain activity alone
Rifan Muazin Sep 17, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ